Travere Therapeutics
TVTX
#3177
Rank
C$6.89 B
Marketcap
C$71.86
Share price
-1.68%
Change (1 day)
42.73%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): C-$1.82

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.85. In 2025 the company made an earnings per share (EPS) of C-$0.41 an increase over its 2024 EPS that were of C-$5.86.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.82339.64%
2025C-$0.41-92.93%
2024C-$5.86154.66%
2023C-$2.30-63.16%
2022C-$6.2544.22%
2021C-$4.33-10.09%
2020C-$4.82
2018C-$3.6364.94%
2017C-$2.20
2015C$5.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.27-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.36-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA